Evidence map›Paper›PMID 36167854›Full record

ArticleNature communications2022

Rejuvenation of the aged brain immune cell landscape in mice through p16-positive senescent cell clearance.

Xu Zhang, Vesselina M Pearsall, Chase M Carver, Elizabeth J Atkinson, Benjamin D S Clarkson, Ethan M Grund, Michelle Baez-Faria, Kevin D Pavelko, Jennifer M Kachergus, Thomas A White and 19 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 4 institutions in 2 countries.

Xu ZhangRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-9784-0481
Vesselina M PearsallRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
Chase M CarverDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
Elizabeth J AtkinsonDivision of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Benjamin D S ClarksonDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-2054-3486
Ethan M GrundMayo Graduate School and Medical Scientist Training Program, Mayo Clinic, Rochester, MN, USA.
Michelle Baez-FariaDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
Kevin D PavelkoDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-7555-1315
Jennifer M KachergusDepartment of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL, USA.
Thomas A WhiteRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-7372-0306
Renee K JohnsonDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Courtney S MaloDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Alan M Gonzalez-SuarezDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-6442-4353
Katayoun AyasoufiDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-3797-0823
Kurt O JohnsonRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
Zachariah P TritzDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Cori E FainDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-8323-6419
Roman H KhadkaDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Mikolaj OgrodnikRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-3137-2037
Diana JurkRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-4486-0857
Yi ZhuRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-3876-3156
Tamara TchkoniaRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-4623-7145
Alexander RevzinDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
James L KirklandRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-1676-4905
Aaron J JohnsonDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Charles L HoweDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-3889-8739
E Aubrey ThompsonDepartment of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL, USA.ORCID 0000-0002-9001-4240
Nathan K LeBrasseurRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-2002-0418
Marissa J SchaferRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA. schafer.marissa@mayo.edu.ORCID 0000-0002-1470-1583
Mayo Clinic in Florida · USMayo Clinic · USMayo Clinic in Arizona · USLudwig Boltzmann Gesellschaft · AT

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
Targeting Cellular Senescence to Extend HealthspanP01AG062413 · NIA · MAYO CLINIC ROCHESTER · PI Nathan K LeBrasseur · 2019 to 2026
$28.7M
PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's DiseaseU54AG044170 · NIA · MAYO CLINIC ROCHESTER · PI KAPOOR, EKTA · 2018 to 2022
$7.7M
Effect of Aging on Preadipocyte DifferentiationR37AG013925 · NIA · MAYO CLINIC ROCHESTER · PI KIRKLAND, JAMES L. · 2016 to 2025
$6.6M
Sex-specific Risk for Vascular Dysfunction and Cognitive DeclineP50AG044170 · NIA · MAYO CLINIC ROCHESTER · PI MILLER, VIRGINIA M · 2012 to 2017
$6.1M
CD8 T cell mediated disruption of Blood Brain Barrier Tight JunctionsR01NS103212 · NINDS · MAYO CLINIC ROCHESTER · PI Aaron J Johnson · 2017 to 2026
$4.6M
Neuronal antigen surveillance and autoimmunity in CNS demyelinating diseaseR01NS115126 · NINDS · MAYO CLINIC ROCHESTER · PI HOWE, CHARLES LEE · 2020 to 2024
$2.9M
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - SupplementRF1NS122174 · NINDS · MAYO CLINIC ROCHESTER · PI JOHNSON, AARON J · 2021 to 2023
$2.0M
Senescent Vascular Cells as Mediators of Cognitive DeclineR00AG058798 · NIA · MAYO CLINIC ROCHESTER · PI SCHAFER, MARISSA JOY · 2021 to 2023
$747k
Senescent Vascular Cells as Mediators of Cognitive DeclineK99AG058798 · NIA · MAYO CLINIC ROCHESTER · PI SCHAFER, MARISSA JOY · 2019 to 2020
$249k
AGING AND STEADINESS TRAININGF32AG005878 · NIA · UNIVERSITY OF COLORADO AT BOULDER · PI TRACY, BRIAN L · 1999 to 2002
$78k
NCI NIH HHS P30 CA015083NIA NIH HHS F32 AG005878NIA NIH HHS K99 AG058798NIA NIH HHS P01 AG062413NIA NIH HHS P50 AG044170NIA NIH HHS R00 AG058798NIA NIH HHS R37 AG013925NIA NIH HHS U54 AG044170NIDDK NIH HHS P30 DK084567NINDS NIH HHS R01 NS103212NINDS NIH HHS R01 NS115126NINDS NIH HHS RF1 NS122174
6 · The paper itself

Abstract

Cellular senescence is a plausible mediator of inflammation-related tissue dysfunction. In the aged brain, senescent cell identities and the mechanisms by which they exert adverse influence are unclear. Here we used high-dimensional molecular profiling, coupled with mechanistic experiments, to study the properties of senescent cells in the aged mouse brain. We show that senescence and inflammatory expression profiles increase with age and are brain region- and sex-specific. p16-positive myeloid cells exhibiting senescent and disease-associated activation signatures, including upregulation of chemoattractant factors, accumulate in the aged mouse brain. Senescent brain myeloid cells promote peripheral immune cell chemotaxis in vitro. Activated resident and infiltrating immune cells increase in the aged brain and are partially restored to youthful levels through p16-positive senescent cell clearance in female p16-InkAttac mice, which is associated with preservation of cognitive function. Our study reveals dynamic remodeling of the brain immune cell landscape in aging and suggests senescent cell targeting as a strategy to counter inflammatory changes and cognitive decline.

Indexed as

Cyclin-Dependent Kinase Inhibitor p16RejuvenationAgingAnimalsBrainCellular SenescenceChemotactic FactorsFemaleMaleMiceChemotactic FactorsCyclin-Dependent Kinase Inhibitor p16

Identifiers

PMID36167854
PMCPMC9515187
OpenAlexW4297199882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.